Abstract
Decaffeinated green coffee and turmeric are recognized for their protective effects against hypertension (HTN) and diabetes mellitus (DM). Combining them into a functional drink, green coffee and turmeric (GCT), offers potential health benefits for managing these conditions. This study explored the bioactivity of GCT in HTN and DM through network biology, identifying intersecting protein targets and their roles in inflammation and glucose metabolism. Key proteins identified were AKT1, CCL2, CXCL8, IL-1β, and IL18. Molecular docking revealed that GCT compounds, particularly Cafestol, Chlorogenic Acid, Kahweol, Curcumin, and Desmethoxycurcumin, interacted strongly with AKT1 at its allosteric site, potentially inhibiting its activity. However, the interactions with other proteins were weak or nonexistent. Molecular dynamics simulations further validated these findings, showing that Cafestol, Chlorogenic Acid, and Kahweol exhibited stable interactions with AKT1 under physiological conditions, while Curcumin was unstable and displaced from the binding site. These results suggest that the protective effects of GCT against HTN and DM are mediated through the inhibition of AKT1, influencing pathways related to inflammation and glucose metabolism
Recommended Citation
Hermanto, Feri Eko; Rohman, Mohammad Saifur; Hose, Victor Alvianoes Guterez; Lukitasari, Mifetika; Nugroho, Dwi Adi; Widodo, Nashi; and Kusumastuty, Inggita
(2026)
"Network Pharmacology of a Decaffeinated Green Coffee–Turmeric Combination: Potential Therapeutic Activity against Hypertension and Diabetes Mellitus,"
Makara Journal of Science: Vol. 30:
Iss.
3, Article 14.
DOI: 10.7454/mss.v30i3.2852
Available at:
https://scholarhub.ui.ac.id/science/vol30/iss3/14
Included in
Bioinformatics Commons, Biomedical Informatics Commons, Natural Products Chemistry and Pharmacognosy Commons, Pharmaceutics and Drug Design Commons
